chartexchange

CADL INVESTORS: Securities Fraud Investigation by Block & Leviton Could Allow Candel Therapeutics Investors to Recover Losses

Newsfile | Nov 18, 2026 3:42 PM EST

Boston, Massachusetts--(Newsfile Corp. - November 18, 2026) - Block & Leviton is investigating Candel Therapeutics (NASDAQ: CADL) for potential securities law violations. Investors who have lost money in their Candel Therapeutics investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/cadl.What is this all about?Block & Leviton is investigating whether Candel Therapeutics may have misled investors about...

Read original article